The Global Agri-Food Advancement Partnership (GAAP), a Saskatchewan-based agri-food investment incubator, has recently completed an investment round into Proxima Research and Development, a biotech startup with groundbreaking technology in microbiology. Proxima specializes in isolating and genetically characterizing microbes for applications that span agriculture, food, and pharmaceutical industries, with innovations like yeast strains for diverse brewing experiences. The backing by GAAP, as expressed by CEO Jay Robinson, signifies an expansion of GAAP’s portfolio offerings for the Canadian market and their vision to nurture companies with expert capabilities. Proxima’s R&D, led by CEO Dr. Zachery Belak and CSO Iain Wallace, gains significant traction from GAAP’s investment, especially in terms of the advanced technological resources now at their disposal. This financial movement is an outgrowth of GAAP’s ongoing relationship with Ag-West Bio, an important node within Saskatchewan’s bioscience sector, which focuses on fostering industry growth through investments and partnerships. Ag-West Bio, in turn, receives funding from governmental bodies including the Saskatchewan Ministry of Agriculture and Agriculture, and Agri-Food Canada’s Canadian Agricultural Partnership program. GAAP’s strategy is to invest in early and rapid-growth companies that hold the promise to enhance efficiency, sustainability, and profitability within the global agri-food sphere, with Proxima now prominently featured as an example of such prospective firms.
“Biotechnology”, “Agriculture”, “Food and Beverage”,”Saskatchewan”, “Canada”
http://www.businesswire.com/news/home/20240115222135/en/Global-Agri-Food-Advancement-Partnership-GAAP-Invests-in-Biotech-Startup-Proxima-Research-Development/?feedref=JjAwJuNHiystnCoBq_hl-bV7DTIYheT0D-1vT4_bKFzt_EW40VMdK6eG-WLfRGUE1fJraLPL1g6AeUGJlCTYs7Oafol48Kkc8KJgZoTHgMu0w8LYSbRdYOj2VdwnuKwa